Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Rare Kidney Disease

Rare Disease news

Rare Disease Today—December 4, 2025

This week’s rare disease update highlights key regulatory designations, early…

Rare Disease news

Rare Diseases Weekly News - June 12th 2025

🔬 Rare Diseases Update: Orphan Drug Wins, Genomic Breakthroughs, Global…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—December 8, 2025
Oncology Today—December 8, 2025
Oncology Video Recap—December 8, 2025
Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing
Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer Ventures

Tags

AAV exit AAV Gene Therapy abbvie ventures ABCA4 ANGPTL3 apixaban BioCryst Pharmaceuticals cannabis Cidara Therapeutics clinical translation CNS therapeutics commercial launches Contera Pharma Diagonal Therapeutics eCOA Eisai Elecsys pTau181 Factor Bioscience Fracture risk genome editing Hypereosinophilic syndrome Ildong oral GLP-1 Infinity innovative designs Jupiter Endovascular Minovia Therapeutics modifiable risk factors mRNA COVID vaccines myotonic dystrophy type 1 narcolepsy type 1 nasopharyngeal carcinoma Nicotine Regulation Non-small cell lung cancer oligonucleotides PDE4 Pivekimab Sunirine prediabetes progressive multiple sclerosis RNAi therapeutics RPDD spesolimab Staphylococcus aureus vaccine Tavapadon Thymus-targeted Tregs XLRS

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—December 8, 2025
Oncology Today—December 8, 2025
Oncology Video Recap—December 8, 2025
Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing
Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer Ventures

TAGS

AAV exit AAV Gene Therapy abbvie ventures ABCA4 ANGPTL3 apixaban BioCryst Pharmaceuticals cannabis Cidara Therapeutics clinical translation CNS therapeutics commercial launches Contera Pharma Diagonal Therapeutics eCOA Eisai Elecsys pTau181 Factor Bioscience Fracture risk genome editing Hypereosinophilic syndrome Ildong oral GLP-1 Infinity innovative designs Jupiter Endovascular Minovia Therapeutics modifiable risk factors mRNA COVID vaccines myotonic dystrophy type 1 narcolepsy type 1 nasopharyngeal carcinoma Nicotine Regulation Non-small cell lung cancer oligonucleotides PDE4 Pivekimab Sunirine prediabetes progressive multiple sclerosis RNAi therapeutics RPDD spesolimab Staphylococcus aureus vaccine Tavapadon Thymus-targeted Tregs XLRS

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy